When Dr. Samir Parikh and his team at UT Southwestern Medical Center in Dallas examined placental tissue from mice nearing the end of pregnancy, they noticed a striking metabolic shift: levels of NAD+, a vital coenzyme involved in cellular energy production, were plummeting. This wasn’t just a side effect—it was a signal. The discovery, published in Science, reveals that the sharp decline in NAD+ in the placenta acts as a biological tipping point, triggering labor across mammalian species. For the first time, scientists have identified a metabolic clock embedded in the placenta that may determine when pregnancy ends.
Preterm birth affects an estimated 15 million babies worldwide each year and is a leading cause of infant mortality and long-term health complications. Yet, despite decades of research, predicting or preventing early labor has remained elusive. The new study offers a breakthrough by linking placental metabolism directly to the timing of delivery. In healthy mouse pregnancies, which last about 18.5 days, artificially lowering NAD+ levels shortened gestation by more than a day—equivalent to weeks in human terms. Conversely, supplementing a preterm mouse model with NAD+ precursors extended pregnancy by nearly a full day, suggesting a potential therapeutic pathway.
The mechanism hinges on a delicate biochemical balance. NAD+ powers an enzyme called 15-PGDH, which normally breaks down prostaglandins—molecules known to induce labor. As NAD+ levels drop near term, 15-PGDH slows down, allowing prostaglandins to accumulate and initiate contractions. When researchers analyzed human placentas from cesarean deliveries before labor began, they found the same pattern: NAD+ and its precursors sharply declined as full term approached, even without active labor.
This metabolic shift appears to reflect a natural tipping point in the mother-fetus nutrient balance. As the growing fetus demands more resources, the placenta’s metabolic capacity reaches its limit, NAD+ falls, and labor begins. “A normal length of pregnancy is vital to the health of the child,” said Parikh. “Our findings identify a metabolic mechanism that may influence the length of pregnancy in both health and disease.”
The implications are profound. Monitoring components of the NAD+-prostaglandin pathway could one day allow clinicians to assess preterm risk or estimate delivery windows more accurately. For at-risk mothers, supplementation with NAD+ precursors—such as nicotinamide riboside, already used in dietary supplements—might help sustain pregnancy longer. Meanwhile, controlled NAD+ depletion could offer a novel method for safely inducing labor when medically necessary.
While clinical applications are still on the horizon, this discovery reframes how we understand the very end of pregnancy—not as a hormonal surprise, but as a metabolically programmed event. As research moves toward human trials, the placenta’s hidden clock may finally give medicine the tools to protect the most vulnerable arrivals.